Tepao Bio: Net profit expected to grow by 24.61% year-over-year in 2025, with a proposed dividend of 6.2 RMB per 10 shares

MetaMuskRat · 2026-03-28T10:57:22+00:00

People's Financial News, March 26 — Trebow Bio(688278) disclosed its annual report on March 26, 2025, with an operating revenue of 3.696 billion yuan, a year-on-year increase of 31.18%; net profit attributable to shareholders of the parent company was 1.031 billion yuan, up 24.61% year-on-year; basic earnings per share were 2.53 yuan. The company plans to distribute a cash dividend of 6.2 yuan for every 10 shares (tax included).

MetaMuskRat

2026-03-28 10:57:22

People’s Finance Network, March 26—Tebao Biologics (688278) disclosed its annual report on March 26. In 2025, the company reported operating revenue of RMB 3.696 billion, up 31.18% year over year; net profit attributable to the parent company of RMB 1.031 billion, up 24.61% year over year; and basic earnings per share of RMB 2.53. The company plans to distribute a cash dividend of RMB 6.2 per 10 shares (tax included).

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

1 Likes